FindTrial
Sign In

Prevalence and impact of anxiety and depression among COPD patients

Prevalence of anxiety and depression among COPD patients and impact on disease progression - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/05/086664
Enrollment
100
Registered
2025-05-09
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J449- Chronic obstructive pulmonary disease, unspecified

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: Nil: Nil Intervention4: Nil: Nil Control Intervention1: Nil: Nil

Sponsors

SINCHANA V SHETTY
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with primary diagnosis of COPD COPD patients aged 18 years and above Patient who signed written informed consent

Exclusion criteria

Exclusion criteria: Patients under 18 years of age. mental disorders impairing capacity for informed consent Patients who are unresponsive, unconscious and comatose Patients who are not willing to participate in the study

Design outcomes

Primary

MeasureTime frame
This study on Chronic Obstructive Pulmonary Disease patients will likely reveal a high prevalence of anxiety and depression, exacerbating symptoms and worsening quality of life. Findings may also show poorer quality of life, high smoking prevalence, sleep disturbances and medication adherence challenges.Timepoint: 0,15,30—

Secondary

MeasureTime frame
NilTimepoint: Nil—

Countries

India

Contacts

Public ContactSINCHANA V SHETTY

Karavali College of Pharmacy

sinchuvshetty@gmail.com8296825697

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026